Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1615 1624
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17771320 | Vaginal Drug Delivery Device | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18525934 | SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND INORGANIC UV FILTERS | Non-Final OA | BASF SE |
| 17961869 | SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND INORGANIC UV FILTERS | Non-Final OA | BASF SE |
| 19285358 | PHARMACEUTICAL COMPOSITION COMPRISING MELOXICAM | Final Rejection | Mylan Laboratories LTD |
| 18618507 | HAIR TREATMENT SERUM AND METHOD OF USE | Non-Final OA | L'OREAL |
| 18029390 | SERUMS FOR REDUCING LIPID PEROXIDATION | Non-Final OA | L'Oreal |
| 18684024 | COMPOSITIONS | Non-Final OA | SYMRISE AG |
| 17641516 | NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKE | Final Rejection | Yale University |
| 18566255 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Non-Final OA | GIVAUDAN SA |
| 18253813 | PLANT EXTRACTING METHOD | Non-Final OA | GIVAUDAN SA |
| 14774101 | COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND FRAGRANCES | Non-Final OA | BEIERSDORF AG |
| 18030176 | Compositions Comprising Silybum Marianum Extract As A Senotherapeutic Agent | Non-Final OA | Clariant International Ltd. |
| 18285002 | SUSTAINED-RELEASE INJECTABLE COMPOSITION CONTAINING NALTREXONE AND METHOD FOR PREPARING SAME | Non-Final OA | INVENTAGE LAB INC. |
| 18125858 | EXTRACT OF SPIRODELA POLYRHIZA AND ITS COSMETIC USES | Final Rejection | SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE |
| 18265935 | DENDROBIUM FIMBRIATUM EXTRACT AND NO-RINSE COSMETIC COMPOSITION COMPRISING SAME | Non-Final OA | L V M H RECHERCHE |
| 18299716 | COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION | Final Rejection | Xygenyx Inc. |
| 17782630 | HISTATIN-1 FORMULATION FOR THE TREATMENT, REPAIR OR REGENERATION OF BONE TISSUE IN A SUBJECT | Final Rejection | UNIVERSIDAD DE CHILE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy